RWANDA

University launches postgraduate biotechnology programmes

The University of Rwanda on 5 April launched new masters and PhD programmes in biotechnology to ensure sustainable local production and improved access to quality assured vaccines, medicines and health technologies, writes Patrick Nzabonimpa for The New Times.

The new programmes follow Rwanda’s vision to become a regional hub for next-generation biomanufacturing. It is supported by Team Europe’s initiative on manufacturing and access to vaccines, medicines and health technologies in Africa (MAV+) under the EU Global Gateway strategy.

As part of it, 25 students (medical doctors, biologists, pharmacists) will be recruited for the masters programme, with each intake aiming to train 100 skilled masters graduates in four years. Five PhD candidates will also be supported while lecturers from European countries will provide distance and onsite training, with a common core in the first year and internship training and research responding to local health needs in the second year.
Full report on The New Times site